Aptamers in Research and Drug Development

被引:0
|
作者
Günter Mayer
Andreas Jenne
机构
[1] NascaCell IP GmbH,Kekulé
[2] Universität Bonn,Institut für Organische Chemie und Biochemie
来源
BioDrugs | 2004年 / 18卷
关键词
Target Validation; Pegaptanib; Human Neutrophil Elastase; Cetrorelix; Cellular Delivery;
D O I
暂无
中图分类号
学科分类号
摘要
Aptamers are short single-stranded oligonucleotides that fold into well defined three-dimensional shapes allowing them to bind to and inhibit their targets with high affinity and specificity. Aptamers can be considered truly multifunctional tools, because they can be generated rapidly and applied for specific detection, inhibition, and characterization of proteins. Recent publications impressively confirm that aptamers can be used either as surrogate inhibitors for the identification of small molecule lead compounds or as biopharmaceuticals.
引用
收藏
页码:351 / 359
页数:8
相关论文
共 50 条
  • [21] TRANSLATIONAL RESEARCH AND DRUG DEVELOPMENT
    Benavides, J.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 2 - 2
  • [22] Drug development research: The process
    Sataloff, Robert T.
    ENT-EAR NOSE & THROAT JOURNAL, 2008, 87 (08) : 420 - +
  • [23] Antibiotic drug research and development
    Paccaud, Jean-Pierre
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [24] Translation research and drug development
    Erickson, J
    SCIENCE, 2006, 312 (5776) : 997 - 997
  • [25] Status and Prospects of Aptamers as Drug Components
    Mattice, Christopher M. C.
    DeRosa, Maria C.
    BIODRUGS, 2015, 29 (03) : 151 - 165
  • [26] Nanotechnology and aptamers: applications in drug delivery
    Levy-Nissenbaum, Etgar
    Radovic-Moreno, Aleksandar F.
    Wang, Andrew Z.
    Langer, Robert
    Farokhzad, Omid C.
    TRENDS IN BIOTECHNOLOGY, 2008, 26 (08) : 442 - 449
  • [27] Status and Prospects of Aptamers as Drug Components
    Christopher M. C. Mattice
    Maria C. DeRosa
    BioDrugs, 2015, 29 : 151 - 165
  • [28] Cancer research and development and the drug development process
    Jonsson, B.
    Wilking, N.
    ANNALS OF ONCOLOGY, 2007, 18 : 49 - 54
  • [29] REENGINEERING DRUG DEVELOPMENT - INTEGRATING PHARMACOECONOMIC RESEARCH INTO THE DRUG DEVELOPMENT PROCESS
    DATA, JL
    WILLKE, RJ
    BARNES, JR
    DIROMA, PJ
    PSYCHOPHARMACOLOGY BULLETIN, 1995, 31 (01) : 67 - 73
  • [30] Development of aptamers for recognition imaging
    Lin, Liyun
    Horn, Doris
    Chaput, John
    Lindsay, Stuart
    BIOCHEMISTRY AND CELL BIOLOGY-BIOCHIMIE ET BIOLOGIE CELLULAIRE, 2007, 85 (04): : 532 - 532